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Sunday, February 26, 2012 135afailed to affect the channel’s total protein level and membrane trafficking.
Our data suggest that 14-3-3 is a novel modulator of rEag1 channels in the
brain.
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Membrane ion channels participate in cancerous processes such as prolifera-
tion, migration and invasion, which contribute to metastasis. Increasing evi-
dence indicates that voltage-dependent Kþ (Kv) channels are involved in the
proliferation of many types of cells, including tumor cells. Kv channels have
generated immense interest as a promising tool for developing new anti-
tumor therapies. Therefore, the identification of potential biomarkers and
therapeutic targets in specific cancers is an important prerequisite for the treat-
ment. Since Kv1.3 and Kv1.5 are involved in the proliferation of many mam-
malian cells, we aimed to study the expression of Kv1.3 and Kv1.5 in a plethora
of human cancers. Thus, tissue from breast, stomach, kidney, bladder, lung,
skin, colon, ovary, pancreas, brain, lymph node, skeletal muscle and some of
their malignant counterparts have been analyzed. Whereas Kv1.3 expression
was either decreased or did not change in most tumors, Kv1.5 was overex-
pressed. However, the presence of Kv1.3 was mostly associated with inflamma-
tory lymphoplasmocytic cells. Independent of the suitability of individual
channels as therapeutic targets, the identification of a Kv phenotype from tumor
specimens could have a diagnostic value of its own. Our results demonstrate
that Kv1.5, and to some extent Kv1.3, are aberrantly expressed in a number
of human cancers. These channels could serve both as novel markers of the
metastatic phenotype and as potential new therapeutic targets. The concept
of Kv channels as therapeutic targets or prognostic biomarkers attracts increas-
ing interest and warrants further investigation.
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Mathematical modeling protein signaling networks is one of the most rapidly
developing fields of science. This includes creation and investigation of the
models for protein signaling systems in the heart cells. b1-adrenergic signal-
ing system is one of the most important systems in cardiac myocytes. We de-
veloped an experimentally-based mathematical models of b1-adrenergic
regulation of L-type Ca2þ current and ryanodine receptors in mouse ventric-
ular myocytes. The model includes several modules and describes signal
transduction in the cells. In the model, b1-adrenergic receptors (b1-ARs) are
stimulated by application of b1-adrenergic agonist isoproterenol. Activation
of b1-ARs in turn activates Gs proteins, Gsa subunit of which subsequently
stimulates cyclic AMP (cAMP) synthesis by adenylyl cyclases. cAMP further
activates protein kinase A (PKA) holoenzyme and dissociates PKA catalytic
subunit from regulatory subunit. cAMP is degraded by phosphodiesterases
(PDEs) that can be inhibited by 3-isobutyl-1-methylxanthine (IBMX). Inhibi-
tion of PDEs by IBMX leads to an increase in cAMP level and more profound
stimulation of PKA. PKA is also regulated by heat-stable protein kinase inhib-
itor. b1-ARs are desensitized by b-adrenergic receptor kinase-1 and by cata-
lytic subunit of PKA that creates negative feedback for this signaling
pathway. PKA phosphorylates L-type Ca2þ channel, which results in an
increase of channel’s opening probability and current amplitude. Phosphory-
lation is removed by protein phosphatases 1 and 2A. We developed a Markov
model for L-type Ca2þ channel that consists of two parallel activation-
inactivation pathways for non-phosphorylated and phosphorylated states.
There are also transitions between corresponding non-phosphorylated and
phosphorylated states in the model (closed, open, or inactivated states).
Similar approach was applied to the Markov model development for ryano-
dine receptors. Both models reproduced experimentally observed behavior
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Numerous G protein-coupled receptors, including the GABAB receptor
(GABABR), provide negative feedback to modulate the activity of neuronal
(N)-type voltage-gated calcium channels (Cav2.2), which play a critical role
in nociception. We have previously shown that analgesic a-conotoxins indi-
rectly inhibit Cav2.2 channels via GABABR activation in mammalian dorsal
root ganglion neurons (1). We reconstituted GABABR-mediated modulation
of stably expressed CaV2.2 channels (a1, a2d and b3) in HEK293 cells, co-
transfected with cDNAs of cloned human GABABR subunits. GABABR ex-
pression was demonstrated using receptors labelled with fluorescent antibodies
against the epitope tags of GABAB1 and GABAB2 subunits. Modulation of
Cav2.2 by the agonists GABA and baclofen, and the a-conotoxins Vc1.1 and
RgIA was studied using the whole-cell recording configuration of the patch
clamp technique. Voltage-dependent Ba2þ currents were inhibited by baclofen,
GABA and a-conotoxins Vc1.1 and RgIA in HEK293 cells transfected with
Cav2.2 and GABABRs but not in cells transfected with Cav2.2 alone. In the
presence of the GABABR, the biophysical properties of the Cav2.2 channels,
including the current-voltage relationship, and activation and steady-state inac-
tivation curves, were unchanged. The concentration-response relationships
obtained for inhibition of Cav2.2 by baclofen, GABA, RgIA, Vc1.1, and
cyclized Vc1.1 resulted in half-maximal inhibitory concentrations (IC50) of
3 mM, 68 nM, 130 nM, 120 nM and 10 nM, respectively. The inhibition by
baclofen and GABA could be reversed by a depolarizing prepulse to þ80 mV,
whereas the effect of the a-conotoxins was slower and unaffected by a prepulse,
suggesting the involvement of a voltage-independent pathway. Taken together,
HEK293 cells provide a suitable expression system to study GABABR modu-
lation of Cav2.2 channels and confirm the role of GABABRs in mediating the
effects of analgesic a-conotoxins.
1. Callaghan et al. (2008) J. Neurosci. 28:10943-51.
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Regulators of G-protein signaling (RGS) are GTPase activating proteins (GAP)
that reduce response amplitudes of activated G-protein coupled receptors
(GPCRs). We discovered that, although RGS proteins drastically accelerate
kinetics of GPCR-coupled Kþ currents (GIRK), they actually increased
amplitudes of inhibitory neurotransmitter-evoked GIRK currents. The RGS-
Box domain alone is sufficient for stimulation of transmitter activation of
Kþ currents, but its membrane association enhances the efficiency of stimula-
tion. Moreover, RGS4 mutants with compromised GAP activity still augment
GPCR-GIRK coupling. Among the pertussis toxin sensitive G-proteins, we
found that RGS4 selectively stimulates G alpha-o to maintain robustness of
GPCR-GIRK coupling. Opposing actions of RGS proteins thus both stimulate
and inhibit G-proteins to modulate ultimate amplitudes of transmitter-induced
GIRK currents and to differentiate signal intensity coupled to various G-protein
isoforms.
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Cytochrome P450s are essential hemoprotein monooxygenases that catalyze
a variety of biochemical processes including drug metabolism, lipid and steroid
biosynthesis, and degradation of pollutants. As an enzyme from Pseudomonas
putida that catalyzes the regio- and stereo-specific hydroxylation of camphor,
cytochrome P450cam has long served as a model system for studying P450s.
Water molecules are known to play an important role in the enzymatic activity
and must be able to enter and exit the active site of P450cam. Here long-
timescale molecular dynamics (MD) simulations (300 ns) are performed on
both the apo- and camphor-bound P450cam. Water diffusion into and out of
